A Cascade of Care for Diabetes in People Living with HIV in a Tertiary Care Center in Mexico City

Overview

Journal HIV Res Clin Pract

Specialties Infectious Diseases
Pharmacology

Date 2024 Oct 8

PMID 39377112

Authors

Cristian E Espejo-Ortiz

Nancy Sierra-Barajas

Angelina Silva-Casarrubias

Lorena Guerrero-Torres

Yanink Caro-Vega

Yamile G Serrano-Pinto

Alvaro Lopez-Iniguez

Juan G Sierra-Madero

Brenda E Crabtree-Ramirez

Affiliations

Soon will be listed here.

Abstract

Background: Diabetes affects 4.5% of people living with HIV in Mexico. This study aims to describe the diabetes cascade of care (DMC) in people with HIV in a tertiary center in Mexico City.

Methods: We conducted a single-center review of people with HIV aged over 18, using medical records of active people enrolled at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ) HIV Clinic (HIVC). Our analysis focused on their last visit to describe the DMC, aiming to identify gaps in control goals. We included people who had a consultation within the 12 months preceding May 2020.

Results: Out of the 2072 active people, medical records were available for 2050 (98.9%). Among these, 326 people (15.9%) had fasting glucose (FG) abnormalities, of which 133 (40.7%) had diabetes. The prevalence of diabetes among people with HIV was of 6.4% (133/2050). Regarding the DMC, the following proportions of people achieved control goals: 133/133 (100%) received medical care in the last 12 months, 123/123 (100%) had blood pressure (BP) <140/90 mmHg, 73/132 (55.3%) had LDL cholesterol (c-LDL) <100 mg/dl, 63/132 (47.7%) had FG <130 mg/dl, 50/116 (43.1%) had glycosylated hemoglobin (HbA1c) <7%. ABC goals (HbA1c <7%, c-LDL <100 mg/dl, BP <140/90 mmHg) were met in 28/109 (25.6%) people. 126/133 (94%) people with HIV achieved HIV-viral load <50 copies/mL.

Conclusions: Despite the high rate of viral suppression among people with HIV and diabetes, significant challenges remain in achieving comprehensive diabetes control. These findings highlight the need for targeted interventions to improve metabolic outcomes and the overall management of diabetes in people with HIV.

References

Ardern C, Katzmarzyk P, Janssen I, Church T, Blair S . Revised Adult Treatment Panel III guidelines and cardiovascular disease mortality in men attending a preventive medical clinic. Circulation. 2005; 112(10):1478-85. DOI: 10.1161/CIRCULATIONAHA.105.548198. View

Wade A, Maposa I, Agongo G, Asiki G, Boua P, Choma S . Diabetes care cascade and associated factors in 10 700 middle-aged adults in four sub-Saharan African countries: a cross-sectional study. BMJ Open. 2023; 13(4):e069193. PMC: 10151877. DOI: 10.1136/bmjopen-2022-069193. View

Meng Li C, Jie Ying F, Raj D, Pui Li W, Kukreja A, Omar S . A retrospective analysis of the care cascades for non-communicable disease and mental health among people living with HIV at a tertiary-care centre in Malaysia: opportunities to identify gaps and optimize care. J Int AIDS Soc. 2020; 23(11):e25638. PMC: 7673263. DOI: 10.1002/jia2.25638. View

Unger T, Borghi C, Charchar F, Khan N, Poulter N, Prabhakaran D . 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020; 75(6):1334-1357. DOI: 10.1161/HYPERTENSIONAHA.120.15026. View

ElSayed N, Aleppo G, Aroda V, Bannuru R, Brown F, Bruemmer D . 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care. 2022; 46(Suppl 1):S19-S40. PMC: 9810477. DOI: 10.2337/dc23-S002. View

Stuart R, Khan O, Abeysuriya R, Kryvchun T, Lysak V, Bredikhina A . Diabetes care cascade in Ukraine: an analysis of breakpoints and opportunities for improved diabetes outcomes. BMC Health Serv Res. 2020; 20(1):409. PMC: 7212677. DOI: 10.1186/s12913-020-05261-y. View

Smiley C, Rebeiro P, Cesar C, Belaunzaran-Zamudio P, Crabtree-Ramirez B, Padgett D . Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort study. Lancet HIV. 2021; 8(5):e266-e273. PMC: 8171816. DOI: 10.1016/S2352-3018(20)30358-1. View

Wandeler G, Johnson L, Egger M . Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: comparisons with general population. Curr Opin HIV AIDS. 2016; 11(5):492-500. PMC: 5055447. DOI: 10.1097/COH.0000000000000298. View

Basto-Abreu A, Barrientos-Gutierrez T, Rojas-Martinez R, Aguilar-Salinas C, Lopez-Olmedo N, De la Cruz-Gongora V . [Prevalence of diabetes and poor glycemic control in Mexico: results from Ensanut 2016.]. Salud Publica Mex. 2019; 62(1):50-59. DOI: 10.21149/10752. View

10.

Trickey A, Sabin C, Burkholder G, Crane H, Monforte A, Egger M . Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies. Lancet HIV. 2023; 10(5):e295-e307. PMC: 10288029. DOI: 10.1016/S2352-3018(23)00028-0. View

11.

Ali M, Bullard K, Gregg E, Del Rio C . A cascade of care for diabetes in the United States: visualizing the gaps. Ann Intern Med. 2014; 161(10):681-9. DOI: 10.7326/M14-0019. View

12.

Warriner A, Burkholder G, Overton E . HIV-related metabolic comorbidities in the current ART era. Infect Dis Clin North Am. 2014; 28(3):457-76. DOI: 10.1016/j.idc.2014.05.003. View

13.

Farahani M, Mulinder H, Farahani A, Marlink R . Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis. Int J STD AIDS. 2016; 28(7):636-650. DOI: 10.1177/0956462416632428. View

14.

. Abridged for Primary Care Providers. Clin Diabetes. 2020; 38(1):10-38. PMC: 6969656. DOI: 10.2337/cd20-as01. View

15.

Basto-Abreu A, Lopez-Olmedo N, Rojas-Martinez R, Aguilar-Salinas C, Moreno-Banda G, Carnalla M . . Salud Publica Mex. 2023; 65:s163-s168. DOI: 10.21149/14832. View

16.

Weber M, Duran Ramirez J, Hentzien M, Cavassini M, Bernasconi E, Hofmann E . Time Trends in Causes of Death in People With HIV: Insights From the Swiss HIV Cohort Study. Clin Infect Dis. 2024; 79(1):177-188. PMC: 11259222. DOI: 10.1093/cid/ciae014. View

17.

Arredondo A, Reyes G . Health disparities from economic burden of diabetes in middle-income countries: evidence from México. PLoS One. 2013; 8(7):e68443. PMC: 3709919. DOI: 10.1371/journal.pone.0068443. View

18.

Kazemian P, Shebl F, McCann N, Walensky R, Wexler D . Evaluation of the Cascade of Diabetes Care in the United States, 2005-2016. JAMA Intern Med. 2019; 179(10):1376-1385. PMC: 6692836. DOI: 10.1001/jamainternmed.2019.2396. View

19.

. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023; 402(10397):203-234. PMC: 10364581. DOI: 10.1016/S0140-6736(23)01301-6. View